home / stock / crnx / crnx articles

CRNX Articles, Crinetics Pharmaceuticals Inc. - From 03/19/24

Stock Information
Company Name: Crinetics Pharmaceuticals Inc.
Stock Symbol: CRNX
Market: NASDAQ
Website: crinetics.com
Menu
CRNX CRNX Quote CRNX Short CRNX News CRNX Articles CRNX Message Board
Get CRNX Alerts

News, Short Squeeze, Breakout and More Instantly...
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday | Benzinga

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday. Shares of National CineMedia, Inc. (NASDAQ: NCMI) jumped 25....
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday | Benzinga

U.S. stocks were higher, with the Nasdaq Composite gaining around 0.5% on Friday. Shares of The Cooper Companies, Inc. (NYSE: COO) rose sharply du...

Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 | Benzinga

SAN DIEGO, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that it will report fourth quarter a...

Crinetics Pharmaceuticals to Participate in the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that Scott Struthers, Ph.D., founder ...
Endocrine Diseases-Focused Crinetics Pharmaceuticals Highlights Favorable Initial Findings From Mid-Stage Study | Benzinga

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) released initial findings from its ongoing open-label Phase 2 carcinoid syndrome (CS) study of pa...

Crinetics Pharmaceuticals to Participate in Upcoming Investor Conferences | Benzinga

SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that company management will particip...

Crinetics Pharmaceuticals Announces November 2023 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

SAN DIEGO, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on t...
Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Benzinga

SAN DIEGO, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), a clinical stage pharmaceutical company focused on t...

Top 4 Health Care Stocks That Should Keep You Up At Night | Benzinga

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indic...

Crinetics Pharmaceuticals to Participate in the Cantor Global Healthcare Conference 2023 | Benzinga

SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) today announced that company management will partici...
Previous 10 Next 10